Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis

Bibliographic Details
Title: Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis
Authors: Yurong Li, Qin Qin, Yumeng Zhang, Yuandong Cao
Source: Current Oncology, Vol 29, Iss 10, Pp 6893-6907 (2022)
Publisher Information: MDPI AG, 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: glioma, IDH1 mutation, magnetic resonance imaging, radiomics, prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Gliomas are the most common primary malignant brain tumors in adults. The fifth edition of the WHO Classification of Tumors of the Central Nervous System, published in 2021, provided molecular and practical approaches to CNS tumor taxonomy. Currently, molecular features are essential for differentiating the histological subtypes of gliomas, and recent studies have emphasized the importance of isocitrate dehydrogenase (IDH) mutations in stratifying biologically distinct subgroups of gliomas. IDH plays a significant role in gliomagenesis, and the association of IDH status with prognosis is very clear. Recently, there has been much progress in conventional MR imaging (cMRI), advanced MR imaging (aMRI), and radiomics, which are widely used in the study of gliomas. These advances have resulted in an improved correlation between MR signs and IDH mutation status, which will complement the prediction of the IDH phenotype. Although imaging cannot currently substitute for genetic tests, imaging findings have shown promising signs of diagnosing glioma subtypes and evaluating the efficacy and prognosis of individualized molecular targeted therapy. This review focuses on the correlation between MRI and MRI-based radiomics and IDH gene-phenotype prediction, discussing the value and application of these techniques in the diagnosis and evaluation of the prognosis of gliomas.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 29100542
1718-7729
1198-0052
Relation: https://www.mdpi.com/1718-7729/29/10/542; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729
DOI: 10.3390/curroncol29100542
Access URL: https://doaj.org/article/e63a6f19c4df4cf9b921fa34837c672b
Accession Number: edsdoj.63a6f19c4df4cf9b921fa34837c672b
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:29100542
17187729
11980052
DOI:10.3390/curroncol29100542
Published in:Current Oncology
Language:English